Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck. Read more about Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck.
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients. Read more about Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters. Read more about Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Read more about The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. Read more about Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.
MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin. Read more about MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.
The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease. Read more about The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Read more about Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas.
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells. Read more about Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.
Leptomeningeal metastasis in breast cancer - a systematic review. Read more about Leptomeningeal metastasis in breast cancer - a systematic review.
